None
Quote | Stealth BioTherapeutics Corp. (NYSE:MITO)
Last: | $ |
---|---|
Change Percent: | -0.85% |
Open: | $2.33 |
Close: | $2.33 |
High: | $2.38 |
Low: | $2.33 |
Volume: | 37,871 |
Last Trade Date Time: | 02/12/2020 04:39:42 pm |
News | Stealth BioTherapeutics Corp. (NYSE:MITO)
Stealth BioTherapeutics Corp Announces Completion of Merger PR Newswire BOSTON , Nov. 16, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the ...
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire SBT-272 Phase 1 safety and tolerability data support further clinical development SBT-272 was neuroprotective...
Message Board Posts | Stealth BioTherapeutics Corp. (NYSE:MITO)
Subject | By | Source | When |
---|---|---|---|
Buying more | INFINITI | investorshub | 06/09/2022 4:00:09 PM |
Agree $$$$ | INFINITI | investorshub | 06/09/2022 11:14:59 AM |
,,,,,,,THIS NEWS SHOULDA SENT THIS.70C PLUS | THEMASTERS_SON | investorshub | 06/08/2022 3:18:09 PM |
Stealth BioTherapeutics Presents New SBT-272 Data Demonstrating Improvement | INFINITI | investorshub | 06/08/2022 12:27:51 PM |
Looks good got in $$$ | INFINITI | investorshub | 06/08/2022 12:24:21 PM |
News, Short Squeeze, Breakout and More Instantly...
Stealth BioTherapeutics Corp. Company Name:
MITO Stock Symbol:
NYSE Market:
Stealth BioTherapeutics Corp Announces Completion of Merger PR Newswire BOSTON , Nov. 16, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the ...
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire SBT-272 Phase 1 safety and tolerability data support further clinical development SBT-272 was neuroprotective...
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders PR Newswire BOSTON , Oct. 7, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage biotechnology company focused o...